img

Global Acne Vulgaris Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Acne Vulgaris Market Research Report 2024

Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin.
According to MRAResearch’s new survey, global Acne Vulgaris market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acne Vulgaris market research.
Acne Vulgaris is seen to occur mostly in adolescence. At puberty androgens due to the increase in sebum production from enlarged sebaceous glands, the glands become blocked.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Acne Vulgaris market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Allergan
Bayer
Cipher
Hygeia Laboratories
Johnson & Johnson
Bausch Health
Novan
Vyome Bioscience
Segment by Type
Tetracycline
Minocycline
Doxycycline
Clindamycin
Others

Segment by Application


Child
Adult
Elderly
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acne Vulgaris report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acne Vulgaris Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Tetracycline
1.2.3 Minocycline
1.2.4 Doxycycline
1.2.5 Clindamycin
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acne Vulgaris Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acne Vulgaris Market Perspective (2018-2033)
2.2 Acne Vulgaris Growth Trends by Region
2.2.1 Global Acne Vulgaris Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Acne Vulgaris Historic Market Size by Region (2018-2023)
2.2.3 Acne Vulgaris Forecasted Market Size by Region (2024-2033)
2.3 Acne Vulgaris Market Dynamics
2.3.1 Acne Vulgaris Industry Trends
2.3.2 Acne Vulgaris Market Drivers
2.3.3 Acne Vulgaris Market Challenges
2.3.4 Acne Vulgaris Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acne Vulgaris Players by Revenue
3.1.1 Global Top Acne Vulgaris Players by Revenue (2018-2023)
3.1.2 Global Acne Vulgaris Revenue Market Share by Players (2018-2023)
3.2 Global Acne Vulgaris Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acne Vulgaris Revenue
3.4 Global Acne Vulgaris Market Concentration Ratio
3.4.1 Global Acne Vulgaris Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Revenue in 2022
3.5 Acne Vulgaris Key Players Head office and Area Served
3.6 Key Players Acne Vulgaris Product Solution and Service
3.7 Date of Enter into Acne Vulgaris Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acne Vulgaris Breakdown Data by Type
4.1 Global Acne Vulgaris Historic Market Size by Type (2018-2023)
4.2 Global Acne Vulgaris Forecasted Market Size by Type (2024-2033)
5 Acne Vulgaris Breakdown Data by Application
5.1 Global Acne Vulgaris Historic Market Size by Application (2018-2023)
5.2 Global Acne Vulgaris Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Acne Vulgaris Market Size (2018-2033)
6.2 North America Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Acne Vulgaris Market Size by Country (2018-2023)
6.4 North America Acne Vulgaris Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acne Vulgaris Market Size (2018-2033)
7.2 Europe Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Acne Vulgaris Market Size by Country (2018-2023)
7.4 Europe Acne Vulgaris Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acne Vulgaris Market Size (2018-2033)
8.2 Asia-Pacific Acne Vulgaris Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Acne Vulgaris Market Size by Region (2018-2023)
8.4 Asia-Pacific Acne Vulgaris Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acne Vulgaris Market Size (2018-2033)
9.2 Latin America Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Acne Vulgaris Market Size by Country (2018-2023)
9.4 Latin America Acne Vulgaris Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acne Vulgaris Market Size (2018-2033)
10.2 Middle East & Africa Acne Vulgaris Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Acne Vulgaris Market Size by Country (2018-2023)
10.4 Middle East & Africa Acne Vulgaris Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Acne Vulgaris Introduction
11.1.4 Allergan Revenue in Acne Vulgaris Business (2018-2023)
11.1.5 Allergan Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Acne Vulgaris Introduction
11.2.4 Bayer Revenue in Acne Vulgaris Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Cipher
11.3.1 Cipher Company Detail
11.3.2 Cipher Business Overview
11.3.3 Cipher Acne Vulgaris Introduction
11.3.4 Cipher Revenue in Acne Vulgaris Business (2018-2023)
11.3.5 Cipher Recent Development
11.4 Hygeia Laboratories
11.4.1 Hygeia Laboratories Company Detail
11.4.2 Hygeia Laboratories Business Overview
11.4.3 Hygeia Laboratories Acne Vulgaris Introduction
11.4.4 Hygeia Laboratories Revenue in Acne Vulgaris Business (2018-2023)
11.4.5 Hygeia Laboratories Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Acne Vulgaris Introduction
11.5.4 Johnson & Johnson Revenue in Acne Vulgaris Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Detail
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Acne Vulgaris Introduction
11.6.4 Bausch Health Revenue in Acne Vulgaris Business (2018-2023)
11.6.5 Bausch Health Recent Development
11.7 Novan
11.7.1 Novan Company Detail
11.7.2 Novan Business Overview
11.7.3 Novan Acne Vulgaris Introduction
11.7.4 Novan Revenue in Acne Vulgaris Business (2018-2023)
11.7.5 Novan Recent Development
11.8 Vyome Bioscience
11.8.1 Vyome Bioscience Company Detail
11.8.2 Vyome Bioscience Business Overview
11.8.3 Vyome Bioscience Acne Vulgaris Introduction
11.8.4 Vyome Bioscience Revenue in Acne Vulgaris Business (2018-2023)
11.8.5 Vyome Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acne Vulgaris Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Tetracycline
Table 3. Key Players of Minocycline
Table 4. Key Players of Doxycycline
Table 5. Key Players of Clindamycin
Table 6. Key Players of Others
Table 7. Global Acne Vulgaris Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Acne Vulgaris Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Acne Vulgaris Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Acne Vulgaris Market Share by Region (2018-2023)
Table 11. Global Acne Vulgaris Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Acne Vulgaris Market Share by Region (2024-2033)
Table 13. Acne Vulgaris Market Trends
Table 14. Acne Vulgaris Market Drivers
Table 15. Acne Vulgaris Market Challenges
Table 16. Acne Vulgaris Market Restraints
Table 17. Global Acne Vulgaris Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Acne Vulgaris Market Share by Players (2018-2023)
Table 19. Global Top Acne Vulgaris Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris as of 2022)
Table 20. Ranking of Global Top Acne Vulgaris Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Acne Vulgaris Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acne Vulgaris Product Solution and Service
Table 24. Date of Enter into Acne Vulgaris Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acne Vulgaris Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Acne Vulgaris Revenue Market Share by Type (2018-2023)
Table 28. Global Acne Vulgaris Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Acne Vulgaris Revenue Market Share by Type (2024-2033)
Table 30. Global Acne Vulgaris Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Acne Vulgaris Revenue Market Share by Application (2018-2023)
Table 32. Global Acne Vulgaris Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Acne Vulgaris Revenue Market Share by Application (2024-2033)
Table 34. North America Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Acne Vulgaris Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Acne Vulgaris Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Acne Vulgaris Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Acne Vulgaris Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Acne Vulgaris Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Acne Vulgaris Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Acne Vulgaris Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Acne Vulgaris Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Acne Vulgaris Market Size by Country (2024-2033) & (US$ Million)
Table 49. Allergan Company Detail
Table 50. Allergan Business Overview
Table 51. Allergan Acne Vulgaris Product
Table 52. Allergan Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 53. Allergan Recent Development
Table 54. Bayer Company Detail
Table 55. Bayer Business Overview
Table 56. Bayer Acne Vulgaris Product
Table 57. Bayer Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 58. Bayer Recent Development
Table 59. Cipher Company Detail
Table 60. Cipher Business Overview
Table 61. Cipher Acne Vulgaris Product
Table 62. Cipher Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 63. Cipher Recent Development
Table 64. Hygeia Laboratories Company Detail
Table 65. Hygeia Laboratories Business Overview
Table 66. Hygeia Laboratories Acne Vulgaris Product
Table 67. Hygeia Laboratories Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 68. Hygeia Laboratories Recent Development
Table 69. Johnson & Johnson Company Detail
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Acne Vulgaris Product
Table 72. Johnson & Johnson Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Development
Table 74. Bausch Health Company Detail
Table 75. Bausch Health Business Overview
Table 76. Bausch Health Acne Vulgaris Product
Table 77. Bausch Health Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 78. Bausch Health Recent Development
Table 79. Novan Company Detail
Table 80. Novan Business Overview
Table 81. Novan Acne Vulgaris Product
Table 82. Novan Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 83. Novan Recent Development
Table 84. Vyome Bioscience Company Detail
Table 85. Vyome Bioscience Business Overview
Table 86. Vyome Bioscience Acne Vulgaris Product
Table 87. Vyome Bioscience Revenue in Acne Vulgaris Business (2018-2023) & (US$ Million)
Table 88. Vyome Bioscience Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acne Vulgaris Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Acne Vulgaris Market Share by Type: 2022 VS 2033
Figure 3. Tetracycline Features
Figure 4. Minocycline Features
Figure 5. Doxycycline Features
Figure 6. Clindamycin Features
Figure 7. Others Features
Figure 8. Global Acne Vulgaris Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Acne Vulgaris Market Share by Application: 2022 VS 2033
Figure 10. Child Case Studies
Figure 11. Adult Case Studies
Figure 12. Elderly Case Studies
Figure 13. Acne Vulgaris Report Years Considered
Figure 14. Global Acne Vulgaris Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Acne Vulgaris Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Acne Vulgaris Market Share by Region: 2022 VS 2033
Figure 17. Global Acne Vulgaris Market Share by Players in 2022
Figure 18. Global Top Acne Vulgaris Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Vulgaris as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Acne Vulgaris Revenue in 2022
Figure 20. North America Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Acne Vulgaris Market Share by Country (2018-2033)
Figure 22. United States Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Acne Vulgaris Market Share by Country (2018-2033)
Figure 26. Germany Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Acne Vulgaris Market Share by Region (2018-2033)
Figure 34. China Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Acne Vulgaris Market Share by Country (2018-2033)
Figure 42. Mexico Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Acne Vulgaris Market Share by Country (2018-2033)
Figure 46. Turkey Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Acne Vulgaris Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Allergan Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 49. Bayer Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 50. Cipher Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 51. Hygeia Laboratories Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 52. Johnson & Johnson Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 53. Bausch Health Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 54. Novan Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 55. Vyome Bioscience Revenue Growth Rate in Acne Vulgaris Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed